ABSTRACT
Dermatomyositis (DM) is a systemic autoimmune disease characterized by proximal muscle weakness and characteristic skin findings. DM may be associated with malign neoplasia. Adult-onset DM has been reported to be associated with internal malignancies at the percentage of 3-40%. Patients diagnosed with DM should be systematically examinated and monitorized with respect to possibility of a malignancy that may be cause of disease. Current case is an example of the association with dermatomiyositis and ovarian cancer. In this article, our aim is to address the features, possible mechanisms related to paraneoplastic DM and the recommended malignancy screening methods.
References
1Bohan A, Peter JB. Polymyositis and dermatomyositis (firt of two parts). Engl J Med 1975; 292: 344-347.
2Bendewald MJ, Wetter DA, Li X, Davis MD. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted Country, Minnesota. Arch Dermatol 2010; 146: 26-30.
3Leatham H, Schadt C, Chisolm S, et al. Evidence supports blind screening for internal malignancy in dermatomyositis: Data from 2 large US dermatology cohorts. Medicine (Baltimore) 2018; 97: e9639.
4Tang MM, Thevarajah S. Paraneoplastic dermatomyositis: A 12-year retrospective review in the department of dermatology hpospital Kuala Lumpur. Med J Malaysia 2010; 65: 138-142.
5Petri MH, Satoh M, Martin-Marquez BT, et al. Implications in the difference of anti-Mi-2 and p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara. Arthritis Res Ther 2013; 15: R48.
6Betteridge ZE, Gunawardena H, Chinoy H, et al. UK Adult Onset Myositis Immunogenetic Collaboration. Clinical and human leukocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-spesific autoantigen target, in UK. Caucasian adult-onset myositis. Ann Rheum Dis 2009; 68: 1621-1625.
7Arshad I, Barton D. Dermatomiyositis as a paranesoplastic phenomenon in ovarian cancer. BMJ Case Rep 2016; 21: 54-63.
8Chao LW, Wei LH. Dermatomiyositis as the initial presentation of ovarian cancer. Taiwan J Obstet Gynecol 2009; 48: 178-180.
9Lu X, Yang H, Shu X, et al. Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta analysis. PLoS One 2014; 9: e94128.
10Best M, Molinari N, Chasset F, Vincent T, Cordel N, Bessis D. Use of anti-transcriptional intermediary factor-1 gamma autoantibody in identifying adult dermatomyositis patients with Cancer: A systematic review and meqta-analysis. Acta Derm Venereol 2019; 99: 256-262.
11Margalioth EJ, Harats N, Ben-Baruch N, Schenker JG. Conccurrence of ovarian cancer and dermatomyositis. A report of two cases and literature review. J Reprod Med 1988; 33: 649-655.
